» Articles » PMID: 30307615

Neurocardiac Regulation: from Cardiac Mechanisms to Novel Therapeutic Approaches

Overview
Journal J Physiol
Specialty Physiology
Date 2018 Oct 12
PMID 30307615
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiac sympathetic overactivity is a well-established contributor to the progression of neurogenic hypertension and heart failure, yet the underlying pathophysiology remains unclear. Recent studies have highlighted the importance of acutely regulated cyclic nucleotides and their effectors in the control of intracellular calcium and exocytosis. Emerging evidence now suggests that a significant component of sympathetic overactivity and enhanced transmission may arise from impaired cyclic nucleotide signalling, resulting from compromised phosphodiesterase activity, as well as alterations in receptor-coupled G-protein activation. In this review, we address some of the key cellular and molecular pathways that contribute to sympathetic overactivity in hypertension and discuss their potential for therapeutic targeting.

Citing Articles

Molecular and cellular neurocardiology in heart disease.

Habecker B, Bers D, Birren S, Chang R, Herring N, Kay M J Physiol. 2024; .

PMID: 38778747 PMC: 11582088. DOI: 10.1113/JP284739.


Oxysterols in Central and Peripheral Synaptic Communication.

Petrov A Adv Exp Med Biol. 2023; 1440:91-123.

PMID: 38036877 DOI: 10.1007/978-3-031-43883-7_6.


Autonomic control of ventricular function in health and disease: current state of the art.

van Weperen V, Ripplinger C, Vaseghi M Clin Auton Res. 2023; 33(4):491-517.

PMID: 37166736 PMC: 10173946. DOI: 10.1007/s10286-023-00948-8.


Cholinergic collaterals arising from noradrenergic sympathetic neurons in mice.

Clyburn C, Li M, Ingram S, Andresen M, Habecker B J Physiol. 2023; 601(7):1247-1264.

PMID: 36797985 PMC: 10065914. DOI: 10.1113/JP284059.


Cellular basis of learning and memory in the carotid body.

Gold O, Bardsley E, Ponnampalam A, Pauza A, Paton J Front Synaptic Neurosci. 2022; 14:902319.

PMID: 36046221 PMC: 9420943. DOI: 10.3389/fnsyn.2022.902319.


References
1.
Wiysonge C, Bradley H, Volmink J, Mayosi B, Opie L . Beta-blockers for hypertension. Cochrane Database Syst Rev. 2017; 1:CD002003. PMC: 5369873. DOI: 10.1002/14651858.CD002003.pub5. View

2.
Watson A, Hood S, Ramchandra R, McAllen R, May C . Increased cardiac sympathetic nerve activity in heart failure is not due to desensitization of the arterial baroreflex. Am J Physiol Heart Circ Physiol. 2007; 293(1):H798-804. PMC: 2084464. DOI: 10.1152/ajpheart.00147.2007. View

3.
Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes T, Thompson J . Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2012; 45(1):25-33. PMC: 3679547. DOI: 10.1038/ng.2480. View

4.
Sauliere A, Bellot M, Paris H, Denis C, Finana F, Hansen J . Deciphering biased-agonism complexity reveals a new active AT1 receptor entity. Nat Chem Biol. 2012; 8(7):622-30. DOI: 10.1038/nchembio.961. View

5.
Zaccolo M, Movsesian M . cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology. Circ Res. 2007; 100(11):1569-78. DOI: 10.1161/CIRCRESAHA.106.144501. View